FORGOT YOUR DETAILS?

2013 Summit Speakers & Advisory Board Members

Speakers

back to summit jenny-evans-200x200 Jenny Evans, CPT, CFT Executive Performance Coach

As a Human Performance Institute performance coach and keynote speaker, Jenny is an internationally recognized expert on stress, exercise physiology, nutrition and performance. Jenny trains hundreds of corporate executives of Fortune 500 companies in energy management for increased productivity and performance. She specializes in both large and small group education and learning.

Her professional experiences include being founder and CEO of PowerHouse Performance Coaching, where she created and developed the PowerHouse Hit the Deck portable fitness program. As NBC KARE 11 TV’s Health & Fitness expert and a published author, she’s committed to being the catalyst that helps others reach their full potential in both their professional and personal lives.

Jenny holds a bachelor of science degree in Kinesiology with an emphasis in Psychology from the University of Minnesota. She serves on the Board of Directors for the National Exercise Trainers Association and has been an A.C.E. Certified Personal Trainer and Group Fitness Instructor for over 15 years.

Jenny has been featured on National Public Radio, as well as in major publications including Shape, Elle, Women’s Health, Redbook, and The Saturday Evening Post. She is a contributing author to the Corporate Athlete Advantage book and has managed corporate wellness centers. In her spare time, Jenny is a competitive athlete, races duathlons and is an aerial arts performer and coach, specializing in tissu and hoop.

The Human Performance Institute, a Division of Wellness & Prevention, Inc., a Johnson & Johnson company, is the pioneer in delivering a science-based energy management training solution to achieve sustained high performance based on over 30 years of proprietary research and working with elite performers including Olympic gold medalists, military Special Forces, Hostage Rescue teams, surgeons, and Fortune 500 CEOs. In 2011 alone, executives from 25 of the Fortune 100 companies participated in the Human Performance Institute’s Corporate Athlete training.

 

back to summit peter-long-200x200 Peter Long President & CEO

Peter Long, Ph.D., is the president and CEO of Blue Shield of California Foundation. He served in leadership roles at the Henry J. Kaiser Family Foundation and The California Endowment. He has extensive experience working on health policy issues at the state, national, and global levels, and has written numerous papers on a variety of health policy topics.

Dr. Long also served as the director of development and programs and then executive director of the Indian Health Center of Santa Clara Valley in San Jose. Previously, he served as a legislative analyst for the National Progressive Primary Health Care Network in Cape Town, South Africa, during the country’s transition to democracy.

He received his bachelor of arts degree from Harvard University; a master’s in health policy from The Johns Hopkins University School of Hygiene and Public Health; and his doctorate in health services from the University of California, Los Angeles.  In 2011, Dr. Long was inducted into the UCLA School of Public Health Alumni Hall of Fame.

back to summit Graham Atkinson Graham Atkinson SVP, Chief Marketing and Customer Experience Officer

Graham Atkinson is senior vice president and chief marketing and customer experience officer for Walgreen Co., based in Deerfield, Ill.

He is responsible for developing and leading the company’s enterprise marketing and loyalty strategies, with a specific emphasis on the customer experience.

Prior to joining Walgreens, Atkinson was president of Mileage Plus for United Airlines, one of the world’s leading customer loyalty programs with more than 50 million members. In that role, he improved the effectiveness of the customer loyalty program and extended the reach and impact of its marketing efforts. While at United, he previously served as executive vice president and chief customer officer and senior vice president-marketing.

Atkinson earned an honors degree in business studies from West London University, Ealing School of Business in London, England, in 1973.

He serves as a board member for the Chicagoland Chamber of Commerce and is a former member of the Chicago Council on Global Affairs.

back to summit Karl Ronn Karl Ronn Managing Director

Managing Director of Innovation Portfolio Partners, a Silicon Valley based firm that helps CEOs and the Top Management Teams of International Fortune 500 companies find and develop new to the world products and services and then to build this capability into their Marketing and R&D organizations.  He also mentors entrepreneurs and creates start-ups to bring category creating new products to market.  The VC funded Butterfly Health start-up he co-founded is creating a new class of health care consumer products to be introduced this fall.

Prior to starting his own innovation firm, Karl was Vice President of Research & Development and General Manager of New Business for The Procter & Gamble Company.  Swiffer, Febreze and Mr. Clean Magic Eraser are billion dollar businesses he helped to create and grow.

In his thirty years with P&G, he was responsible for the Global R&D for Pharmaceuticals and Over-the-Counter Health Care including among other brands, Actonel, Vicks, Prilosec, Pepto Bismol, Align and In-home Diagnostic Tests.  Prior to Health Care he was responsible for Household Cleaning Products and Gillette’s Duracell Batteries.  He has also managed Beauty Care businesses and started up P&G’s Diaper and Maxipad businesses across Latin America.  Corporately he was responsible for developing the Company’s overall capability to create Disruptive Innovations working with Dr. Clayton Christensen’s group.

He is on the Johns Hopkins Bloomberg School of Public Health Advisory Board, the University of Toledo College of Engineering Advisory Board as a Distinguished Alumni of the University of Toledo’s College of Engineering.  He served on the Board of Directors of the Cincinnati Symphony as leader of the Board’s Patron Development Committee, Executive Committee, Music Director Search Committee and past member of the CEO Search.  He is a member of TED conference and has been a speaker at the Mayo Clinic Transform Symposium, Consumer Medical Conference, and Harvard Business School.

Karl is married to Elizabeth Ronn, a former P&G Marketing Vice-President.  They have two children and reside in Palo Alto, California.

back to summit Sukhinder Singh Cassidy Sukhinder Singh Cassidy Founder & Chairman

Sukhinder Singh Cassidy is Founder & CEO of JOYUS, the web’s first premium video shopping network online.  Prior to founding JOYUS in January 2011, she has been a leading consumer internet and media executive with over 18 years of leadership experience at global and early stage companies including Google, Amazon, Yodlee, and News Corp.
Most recently, Ms Singh Cassidy served as CEO and Chairman of the board at the leading social commerce site, Polyvore, Inc, and CEO-in-Residence with Accel Partners, a leading global consumer internet venture capital firm, whose investments include Facebook, Groupon, Admob, and Diapers.com.

From 2003 to 2009, Ms. Singh Cassidy was a senior executive at Google, Inc, where she grew and scaled several leading businesses, including Asia-Pacific & Latin American Operations.  As President of Asia Pacific and Latin America, she was responsible for all of Google’s commercial operations in both regions, and built the company’s physical presence from inception to a multi-billion dollar business serving users, advertisers and partners across 40 domains and 103 different countries throughout APAC and Latin America. Under her leadership the company opened 18 sales offices, 9 R&D centers and full cross-functional operations throughout the region and was the fastest growing geography within the company.

Prior to running Asia Pacific and Latin America, Ms. Singh Cassidy was the first General Manager for Google Local & Maps,  Books, and Video helping to launch these innovative new services.  Previously Sukhinder drove sales and business development for Amazon.com. and Yodlee.com   Sukhinder started her career with News Corp and Merrill Lynch in New York and London.

For her work in the Internet industry, Ms. Singh Cassidy has been profiled in numerous publications globally, including Fortune, Forbes, WSJ, Business Week, Ad Age, Canada Post, India Today, and the book, Innovation Nation, profiling Canada’s most innovative business leaders. Most recently she was named one of the Top 100 People in the Valley by Business Insider in 2012, one of the top 100 Women of Influence in the Bay Area in 2010, a “Woman to Watch” by Ad Age in 2010, and Fortune in 2008, and Techcrunch’s first General Management Fellow in 2009.
Sukhinder currently serves on the board of TripAdvisor, Inc (TRIP), and J. Hilburn.  She has previously served as an advisor to Twitter, and on the board of J. Crew Group Inc. (JCG).  Sukhinder also sits on Princeton University’s Computer Science Advisory Council.  She is a graduate of the Ivey School of Business Administration at the University of Western Ontario, Canada and is married with three children.

back to summit Jimmy Rosenburg Jimmy Rosenberg Founder
back to summit Mary Fisher Mary Fisher President, CEO, Board Director

Ms. Fisher is Colorescience President, Chief Executive Officer and Board Director. Prior to that, she served as Chief Executive Officer and Board Director at SkinMedica from April 2008 until its acquisition for $350 million in December 2012 with an additional $25 million contingent on a sales milestone. Ms. Fisher brings more than 25 years of experience in the aesthetics, pharmaceutical and biotechnology industries including service as Chief Operating Officer of Acorda Therapeutics, a CNS company, with responsibility for corporate strategy and business development, financial planning, sales and marketing, and manufacturing. Previously, Ms. Fisher was Vice President, Strategic Healthcare and Commercial Operations for Cephalon, with responsibility for product planning and marketing, managed care sales, and manufacturing. Her earlier experience includes positions at Immunex and Boehringer Ingelheim. She is also a member of the board of ZELTIQ, a member of the board of OvaScience, and a trustee of the Board of the Neuroscience Nursing Foundation.

back to summit Peter Rose Peter Rose Executive Vice President

As Executive Vice President at The Futures Company, Pete Rose is in charge of consulting efforts throughout the firm’s West and Midwest Regions. He consults with clients in a wide variety of industries on the implications of the Yankelovich MONITOR®, the foremost study of U.S. consumer lifestyles and attitudes. Pete manages client relationships in food and beverage, grocery and other retail, consumer packaged goods, health and wellness, financial services, and travel and leisure.

Originally with the firm (née Yankelovich) from 1989 to 1994, Pete returned to the business in the fall of 2003. He is a frequent speaker on the topic of American generations and has been quoted in publications such as the New York Times, Wall Street Journal, Los Angeles Times and Parents Magazine.

Pete’s consulting career includes seven years at Towers Perrin, a leading HR consulting firm. He specialized in customer and employee research and organization effectiveness, identifying the linkages between employee engagement and business results. He also has extensive experience in project management and client facilitation.

Pete earned a B.A. in history from Yale University and an M.B.A. from the Anderson School at UCLA. He lives in Los Angeles with his wife Debbie and their three children.

back to summit Ashley Koff Ashley Koff, R.D. Nutrition Expert, Health Advocate

Ashley Koff RD (www.AshleyKoffApproved.com) is an internationally renowned registered dietitian on a mission to improve the health of people across America and beyond through raising public awareness of the value of quality eating. A self-described “Qualitarian,” Koff advocates eating the better quality foods available—choosing whole foods over processed parts, natural over made in a chemistry lab and organic whenever possible to avoid hormones, synthetic fertilizers, GMOs and harmful pesticides—to optimally fuel the body. She created the Ashley Koff Approved (AKA) list as a tool to help healthcare practitioners and health-interested consumers choose groceries, dietary supplements, and prepared food options of better quality. Her selections are based on rigorous standards of nutrition, sourcing methods, and marketing integrity, backed by extensive research and globe-spanning travels to get the whole food story.

Widely sought for her knowledge and ability to translate nutrition science into practical and motivating messages, Koff regularly appears on national television programs, including The Dr. Oz Show, The Doctors, and national and local news programs. She is also frequently featured in and writes articles for national publications, including The New York Times, O!: The Oprah Magazine, Every Day with Rachael Ray, Redbook, and Women’s Health. She created and was the lead expert for Huffington Post Living’s “Total Energy Makeover with Ashley Koff RD” which aired monthly on Good Morning America Health, and is the featured dietitian for Deepak Chopra’s new YouTube Channel show, 30 Days of Intent. She was the featured dietitian on both the CW’s Shedding for the Wedding and Lifetime’s Love Handles. Off camera, she has been a nutrition consultant for over 10 years, seeing patients referred by some of the country’s leading doctors—Dr. Andrew Weil, Dr. Woodson Merrell, and Dr. Soram Khalsa, among others. Based on the need expressed by many of her entertainment industry clients, Koff started and continues to manage her AKA Craft Services makeover project for popular shows like ABC’s Private Practice, CBS’ CSI: New York, HBO’s Big Love, FOX’s Bones, and FX’s It’s Always Sunny in Philadelphia, as well several major movies. In addition, she is currently a contributing editor for Natural Health Magazine, on the advisory board of Fitness Magazine, on the editorial advisory board for Prevention magazine, a spokesperson for several national brands, and writes for several blogs including The Huffington Post.

Recently recognized by natural foods industry leader New Hope 360 as one of the leading “50 Natural Influencers” in health and nutrition to follow on Twitter, Ashley Koff has also been named among the Top 10 Registered Dietitians in the US by Today’s Dietitian Magazine and the Best of LA’s “Nutritionist/Dietitians” by CitySearch, three years running. A respected industry advisor, speaking at conferences like Natural Products Expos East and West, she is also a leadership team member of the Natural Resource Defense Council, one of the nation’s most effective environmental action groups, as well as an avid supporter of and the California state ambassador for First Lady Michelle Obama’s “Let’s Move” campaign.

Ashley Koff is the author of Mom Energy: A Simple Plan to Live Fully Charged (Hay House; 2011) as well as Recipes for IBS (Fair Winds Press; 2007) and contributed chapters to several medical textbooks. She maintains a private practice, with celebrities such as Molly Sims, Emily Deschanel, Amy Breneman, Andy Richter, KaDee Strickland, and Elizabeth Hasselbeck among her clients. She also serves on the faculty of the Continuum Center for Health and Healing at the Beth Israel Medical Center in New York City. Koff was educated at both Duke and New York Universities and trained at LA+USC and Columbus Children’s hospitals. She completed coursework for Certified Clinical Nutritionist (CCN) and continues her education with online integrative medicine modules and conferences.

back to summit Warren Teichner Warren Teichner Principal

Warren Teichner is a Principal in McKinsey & Company’s New Jersey Office. He is a member of the consumer goods and health care practice and focuses on serving clients in the consumer health and packaged goods industry and is the co-leader of the Consumer Health Practice. Warren originally joined McKinsey in their Johannesburg office in 2001 and transferred to New Jersey in 2004.

His most recent projects include:

  • Developing a global expansion strategy for a leading OTC/Consumer business focused on building their OTC business outside of the US
  • Developing a regulatory policy strategy and process for food and drug regulatory agency
  • Identifying global growth opportunities (both organic, partnership and acquisition) for a multi-national consumer health and nutrition business
  • Conducting a due-diligence on vitamins company
  • Designing a growth strategy for a global OTC/Consumer business in Central and Eastern Europe
  • Integrating two global, multi-billion dollar consumer organizations
  • Designing a private label expansion strategy in OTC and vitamin categories
  • Designing a brand and customer segmentation and go-to-market strategy for a multi-national alcoholic beverage company

Prior to joining McKinsey, Warren worked in the accounting and corporate finance department at Grant Thornton and as a lecturer at the University of Witwatersrand.

Warren has a Masters in Commerce (Finance and Accounting) from the University of Witwatersrand in Johannesburg and a M.B.A in Finance from Columbia Business School.

back to summit Rachel Winokur Rachel Winokur Head of Business Development

Rachel Winokur is a member of Healthagen’s senior leadership team.  Healthagen is the business responsible for acquiring, creating, building and operating non-insurance healthcare companies within Aetna.  Rachel leads mergers and acquisitions, strategy, and the development and operations of these emerging businesses.

Rachel joined Aetna from the Carlyle Group, a global private equity firm, where she invested in healthcare companies for Carlyle’s US Growth Equity Fund.  Prior to that role, Rachel was Vice President of Business Development and a corporate officer of Datascope, a publicly-traded medical devices company focused on cardiovascular medicine and critical care that was acquired by Mindray and Gettinge.  Previously, she spent several years in operations and business development with Bertelsmann, a global media company.  Rachel started her career at Goldman Sachs in the mergers and acquisitions and equity capital markets departments.

Rachel received an MBA from Stanford University’s Graduate School of Business and a BSE with honors in Biomedical Engineering and Electrical Engineering from Duke University.

back to summit Ginger Graham Ginger Graham President and CEO

Ginger Graham is the President and CEO of Two Trees Consulting.  She consults to first-time CEO’s in the areas of leadership, strategy, board-effectiveness, and organization-building.

She is the former President and Chief Executive Officer of Amylin Pharmaceuticals, a biopharmaceutical company based in San Diego, CA, focused on diabetes and obesity.  During Ginger’s tenure at Amylin, the company launched two first-in-class medicines for people with diabetes, was listed on the Nasdaq 100 and was rated as one of the Top 10 places in the industry for scientists to work.

Prior to her time at Amylin, Ginger was Group Chairman, Office of the President for Guidant Corporation, a major cardiovascular medical device manufacturer based in Indianapolis, IN.  During Ginger’s tenure at Guidant, the company launched the world’s leading stent platform, was listed in the Fortune 500, was recognized by Fortune Magazine as one of the Best Companies to Work For in America, and was included in Industry Week Magazine’s 100 Best Managed Companies in the World.

Ginger has received numerous awards and honors including being named as the Emerging Company Executive of the Year by the Global Health Council in 2005, a Finalist in Marketwatch’s CEO of the Year in 2006, and named as the American Diabetes Association’s Woman of Valor award in 2006.  She was included in Pharma VOICE’s “100 of the Most Inspiring People” list in 2006 and World Pharmaceuticals magazine named her number 10 on a list of 40 most influential people in the industry in 2007.  Ginger was the first woman CEO named to the PhRMA Board and Executive Committee.

Ms. Graham serves on the Boards of Directors for Walgreen Co., Genomic Health, Inc., Proteus Digital Health Pharmaceutical Division, Surefire Medical, Elcelyx Therapeutics and the Circle of Life Hospice Foundation.  Ms. Graham is a member of the Harvard Business School Health Industry Alumni Advisory Board, The University of Arkansas Chancellor’s Campaign Steering Committee and the Advisory Board for the BioFrontiers Institute at the University of Colorado.  She also serves on the Advisory Board for the Kellogg Center for Executive Women and co-chairs the Scientific Council of the University of Colorado’s Center for Women’s Health Research.  Graham taught entrepreneurship at Harvard Business School and has written for Harvard Business Review.

Ginger received a Bachelor of Science in agricultural economics from the University of Arkansas, and holds an MBA, with distinction, from Harvard University.

 

back to summit Kevin Volpp Kevin Volpp, MD, PhD Founding Director

Dr. Kevin Volpp is the founding Director of the Leonard Davis Institute Center for Health Incentives and Behavioral Economics, which is the home of one of two NIH- funded Centers on Behavioral Economics and Health, and the Director of the University of Pennsylvania Health System Center on Innovations in Health Care Financing. He is also a Professor of Medicine at the Perelman School of Medicine and of Health Care Management at the Wharton School of the University of Pennsylvania.

Dr. Volpp’s research program focuses on the impact of financial and organizational incentives on health outcomes. His work has been published in journals such as the New England Journal of Medicine, the Journal of the American Medical Association, and Health Affairs and has been covered by media outlets such as the New York Times, the Wall Street Journal, the Los Angeles Times, Good Morning America, the BBC, National Public Radio, Time, US News and World Report, USA Today, Der Spiegel, and Australian National Radio. A recent intervention study on financial incentives and smoking cessation among employees at General Electric resulted in tripling of long-term smoking cessation rates and implementation of a program based on this approach nationally among all 152,000 GE employees in the U.S. and was the winner of the 2010 British Medical Journal Group Award for Translating Research into Practice.

Dr. Volpp’s work has been recognized by the John Thompson Prize from the Association of University Programs in Health Administration; the Presidential Early Career Award for Scientists and Engineers (PECASE), an award presented at the White House as the highest honor given by the US government to early career scientists; the Outstanding Junior Investigator of the Year Award from the Society of General Internal Medicine; the Alice S. Hersh New Investigator Award from AcademyHealth; Time Magazine’s 2009 A-Z “Advances in Health” list for work on Incentives – letter “I”; and was cited for the most outstanding research paper of the year in 2010 from the Society of General Internal Medicine. He is an elected member of the American Society of Clinical Investigation (ASCI) and has served as an advisor to a number of organizations including the Veterans Administration, the Accreditation Council of Graduate Medical Education (ACGME), the National Institutes of Health, CVS Caremark, Ascension Health, McKinsey, Wellpoint, and Horizon Blue Cross Blue Shield, and is a member of the editorial board of the Annals of Internal Medicine.

Dr. Volpp holds a M.D. from the University of Pennsylvania School of Medicine, a Ph.D. from the Wharton School in Applied Economics and Managerial Science, and a bachelor’s degree from Harvard University. He completed his Internal Medicine residency training at the Brigham and Women’s Hospital and is a board-certified general internist and practicing physician.

back to summit Jody Holtzman Jody Holtzman SVP, Thought Leadership

Jody Holtzman has more than two decades of experience helping companies develop and implement competitive strategies and achieve their strategic market goals.  At AARP, he leads the Thought Leadership group, where his focus is to stimulate innovation in the market that benefits people over 50. This involves areas such as the future of technology and the 50+, technology design for all, and 50+ entrepreneurship. It also involves developing partnerships with non-traditional players for AARP, such as the venture capital community, and the consumer electronics and technology industries. Previously, Jody led AARP’s Research and Strategic Analysis group.

Before joining AARP, Jody was in senior leadership roles in several strategy consulting firms. He was a Director of Global Strategy and Planning, and led the Market Intelligence Network of PricewaterhouseCoopers. Before that, he was Vice President of Consulting for FutureBrand, where he helped clients develop and implement competitive brand strategies.

Jody is a frequent speaker on the opportunities and challenges presented by the demographic wave. He has led numerous workshops on competitive strategy and organizational performance, and his work has been published in the Journal of Business Strategy, Competitive Intelligence Magazine, The Competitive Intelligence Anthology, and Making Cents Out of Knowledge Management. He has a graduate degree in international political economy from the University of Chicago.

back to summit Jeff Arnold Jeff Arnold Chairman and CEO

Jeff Arnold is the Chairman and Chief Executive Officer of Sharecare, a leading health and wellness social network launched in October 2010 by he and Dr. Mehmet Oz in partnership with Harpo Studios, Sony Pictures Television and Discovery Communications.  Sharecare helps people to live a healthier life by intelligently connecting them to personalized resources including high-quality information from leading experts, interactive tools to actively manage their health and local healthcare providers.

Previously, Mr. Arnold was the Chairman and Chief Executive Officer of HowStuffWorks.com, an award-winning, online resource for millions of people each month, which he sold in 2007 for $250 million to Discovery Communications, where he served as Chief Executive Officer of HowStuffWorks and Chief Digital Strategy Officer for Discovery until 2010 and continues to serve as Chairman Emeritus of HowStuffWorks.com.  In 2004, Mr. Arnold and the team at HowStuffWorks worked in partnership with President Clinton and the Clinton Presidential Library to build and launch www.clintonpresidentialcenter.org, an interactive and educational platform for the historical records and ongoing work of President Clinton.

Prior to HowStuffWorks.com, he founded and served as CEO of WebMD Corporation, the first healthcare company to harness the power of the Internet to create a destination for consumers, healthcare institutions and physicians to find trustworthy medical information. Between August 1998 and September 2000, Mr. Arnold negotiated more than 10 acquisitions, growing WebMD from 60 people and $75,000 in annual revenue to more than 5,000 people and revenue of nearly $1 billion in 2001.  Before founding WebMD, Mr. Arnold started Quality Diagnostic Services (QDS), which he grew into a leading cardiac arrhythmia monitoring company, ultimately selling the company to Matria Healthcare in 1998.

Mr. Arnold has served as a Director on numerous private and public company boards throughout his career.  Currently, he serves as the Chairman of Forbes Travel Guide, formerly Mobil Travel Guide, the gold standard of travel ratings and reviews for over 50 years.  Mr. Arnold is a member of the American Academy of Achievement and a Global Leader of Tomorrow, sponsored by the World Economic Forum.

Advisory Board

back to summit Tracey Griffin Tracey Griffin Senior Partner

Tracey is a Senior Partner in the Washington, DC Office. She splits her time between Consumer Goods/Food and Healthcare, with specific focus on Consumer Health. Tracey leads the Firm’s initiative on Consumer Healthcare. She previously sat on the GMA Advisory Board and during that time worked with the industry on childhood obesity. During her time with McKinsey, Tracey has worked with a wide range of companies in the areas of strategy, business development, marketing and sales and organizational effectiveness/redesign. Examples of her recent relevant work include:

  • 5-year growth and organizational strategy for a global consumer health business
  • Exploration of Rx-to-OTC switch opportunities for a pharmaceutical company
  • Social media strategy and organization design for a global consumer health company
  • Strategic review for a consumer healthcare company exploring new growth platforms across food, orals, services and devices
  • Market entry strategy for an Asian functional beverage company seeking to expand in the U.S.
  • Market entry strategy study for a high-end European cosmeceutical player seeking to enter the U.S.
  • Global business and alliance/partnering strategy for a personal care company
  • Marketing capability assessment and program for a pharmaceutical company

Before joining McKinsey, Tracey worked for Procter & Gamble in brand management in the Cosmetics and Fragrances Division. Before that, she was an analyst at PaineWebber, structuring and marketing high-yield securities and leveraged buyouts. Tracey has a B.S. in Finance from Georgetown University and a M.B.A. from Stanford Graduate School of Business.

back to summit Benjamin Wiegand, PhD Benjamin Wiegand, PhD VP and Global Head

Benjamin C. Wiegand, Ph.D. is Vice President, Global Open Innovation and New Business Models R&D.  In this role, he is responsible for developing core strategic and scientific partnerships to bring disruptive innovation to our current and future growth areas for Johnson & Johnson Consumer Companies.  As part of these efforts, he is also working to develop new business and funding models to accelerate these new growth opportunities.

Prior to this role, Ben was the General Manager, Employer Franchise and Vice President, Science and Innovation, Wellness & Prevention, Inc.   In this role, he had overall responsibility for the Employer Franchise of the Wellness & Prevention business, which focuses on providing health & performance solutions to large and jumbo employers to help them effectively manage their health care costs as well as improve employee productivity.  In addition, he led the overall Science & Innovation efforts to support the Wellness & Prevention enterprise, compassing both the innovation development engine of the organization, as well as measuring and communicating the wide range of industry leading outcomes associated with Wellness & Prevention’s suite of solutions.

Ben was with the Wellness & Prevention business since its inception in 2008, working with a cross functional team to demonstrate the strategic importance of this new business to the Johnson & Johnson family of companies.  As part of that strategic effort, he served as a core member of the Johnson & Johnson Diligence team in recommendation of the HealthMedia, Inc. acquisition. He also led the Research & Development and Intellectual Property Assessment, and worked on the business model development.

Ben has worked at Johnson & Johnson for over 15 years, with experiences in a wide range of the Johnson & Johnson Consumer businesses.   He has a broad range of experience in both short term product development as well as long term innovation.  In that role, he was named a 2008 Johnson Medal recipient for his work on key behavioral studies of the effect of rituals in improving infant sleep behaviors.

Ben holds a B.S. degree in Chemistry from the University of Illinois, and both a M.A. and Ph.D. in Physical Chemistry from Harvard University.

back to summit Sue Siegel Sue Siegel CEO, healthymagination

Sue Siegel leads healthymagination, GE’s $6B commitment to enable better health for more people, and GE Ventures’ healthymagination Fund.   Healthymagination applies GE’s scale to transform healthcare by incubating innovative businesses, processes, and solutions to increase its quality, access, and affordability.

Previously, Ms. Siegel led investments in personalized medicine, digital health, and life sciences as a Silicon Valley-based venture capitalist.  Before her VC years, Ms. Siegel  dedicated over 20 years driving the growth of breakthrough technologies at Bio-Rad, DuPont, Amersham, and Affymetrix (NASDAQ: AFFX).  As President and Board Member of Affymetrix, Ms. Siegel built shareholder value, leading its transformation from a pre-revenue start up into a global, multi-billion dollar market cap genomics leader.

Ms. Siegel serves or has served on over a dozen private and public corporate boards.  She currently serves on Stanford Hospital Board’s IT Committee, as a board member of the NIH’s National Center for Advancing Translational Sciences Cures Acceleration Network, and serves on the Executive Committee of Santa Clara University’s Center for Science, Technology, and Society’s Board.  In May, 2013, Ms. Siegel will serve on the National Venture Capital Association Board beginning in May 2013.  She is a President’s Circle member of the National Academies of Science, a Henry Crown Fellow of the Aspen Institute, a member of YPO-WPO, and of Women Corporate Directors.  In the bestselling business book:  Multipliers: How The Best Leaders Make Everyone Smarter, Ms. Siegel was a featured “Multiplier”.  In 2010, she was recognized as one of “The 100 Most Influential Women in Silicon Valley”.  With Stanford Hospital, Ms. Siegel co-founded Checking-In™, a program dedicated to serving the local aging population. She is Board Member Emeritus of the Silicon Valley Tech Museum and served on The Gladstone Advisory Council.

back to summit Eric Meyer Eric Meyer Principal

Mr. Meyer is Principal of Eric Meyer Consulting, LLC, which advises emerging-stage companies launching novel consumer medical, health and wellness products. Mr. Meyer creates go-to-market strategies that integrate branding, consumer direct response (online and offline), professional recommendation and retail. Mr. Meyer’s consulting practice includes clients across a broad range of fields including sleep medicine, ENT, hearing, fitness, beauty and aesthetics.  Mr. Meyer has served his clients as advisor, board member, consultant or interim executive.

Prior to his consulting practice, Mr. Meyer served as CEO of TrafficGauge Inc., which developed and brought to market the first real-time hand-held traffic map.  TrafficGauge was sold to Networks In Motion in early 2009.  Prior to TrafficGauge Mr. Meyer served in senior executive roles in marketing, sales, business development, and R&D for Optiva Corporation, makers of the Sonicare® sonic toothbrush, over a nine year period from pre-launch through successful sale of the company to Philips Electronics.   As Optiva’s 12th employee and first sales and marketing executive, Mr. Meyer led Sonicare to the #1 dollar share power toothbrush brand in the U.S., with Optiva being named Inc. Magazine’s #1 fastest growing privately-held company.  Prior to Optiva, Mr. Meyer served in senior marketing and sales positions at LifeScan in Milpitas California where he launched the One TouchÒ blood glucose monitor.  During his tenure LifeScan was successfully sold to Johnson & Johnson.  Mr. Meyer has served on Boards of Directors of Orahealth Inc., Advanced H2O and Vapore Inc.  Mr. Meyer holds B.S. in Industrial and Operations Engineering and Bachelor of General Studies degrees from the University of Michigan and an MBA from Stanford University.

 

back to summit Bill Humphries Bill Humphries CEO

Bill Humphries joined Merz, Inc. (affiliate of Merz Pharma Group), as President and Chief Executive Officer of its North American business in March of 2012. He is a member of the Merz Pharma Board and the Chairman of the Merz Pharmaceuticals LLC Board, Merz Aesthetics Board and the Merz Canada Board.

As CEO, Bill develops and implements overall strategies, manages operations, evaluates financial growth and enhances the ethical culture of the company. Bill is responsible for the continued and accelerated growth of the Aesthetics, Dermatology, OTX/OTX and Neurology businesses within North America. Through expansion, Bill hopes to capitalize on innovation and trends that impact the four business specialties and to focus on product diversification; Bill believes that the North American business is in a position to use its competitive capabilities in order to become a leader in every segment that the company serves.

Bill has more than 25 years of experience in the specialty pharmaceutical industry, with more than 22 of those years focused on the commercialization of dermatology specialty pharmaceutical products.
In August 2009, Bill was appointed President of Stiefel, a GSK company, after Stiefel Laboratories was successfully acquired by GlaxoSmithkline (GSK) in July 2009 for $3.6 billion dollars. Bill was a key leader in this sale and was the commercial lead for the global integration of Stiefel into GSK.

From April 2008 to August 2009, Bill served as President of Stiefel Laboratories. Previously, Bill was Senior Vice President, US Commercial Operations and Chief Commercial Officer. Beginning in April 2006, he served as a member of the Company’s Board of Directors. Bill was a key leader in two major acquisitions for Stiefel: Barrier Therapeutics, Inc., which was completed in 2008, and Connetics Corporation, which was completed in 2006. During his tenure at Stiefel, Bill spearheaded the development of the company’s global commercial infrastructure, commercialization of its product portfolio, and managed worldwide operational initiatives.

From 1996 to 2004, Bill served in numerous executive roles in sales and marketing, business development, and international marketing for Allergan, Inc. He completed his tenure with Allergan, Inc. as Vice President US Skin Care, where he successfully led the Skin Care business back to profitable growth and was a key colleague in the launch of Botox Cosmetic to Dermatologists.

Bill has served on the board of ZARS Pharma, a privately held specialty pharmaceutical company with a focus on pain and delivery technologies, the GlaxoSmithKline Portfolio Investment Board and GlaxoSmithKline Ophthalmology Board. He currently serves on the Board of Clearside Biomedical, an ophthalmology therapeutics company. Bill received a Master’s degree in Business Administration from Pepperdine University in Malibu, California. He completed his undergraduate studies at Bucknell University in Lewisburg, Pennsylvania, earning a Bachelor of Arts degree.

back to summit Ginger Graham Ginger Graham President and CEO

Ginger Graham is the President and CEO of Two Trees Consulting.  She consults to first-time CEO’s in the areas of leadership, strategy, board-effectiveness, and organization-building.

She is the former President and Chief Executive Officer of Amylin Pharmaceuticals, a biopharmaceutical company based in San Diego, CA, focused on diabetes and obesity.  During Ginger’s tenure at Amylin, the company launched two first-in-class medicines for people with diabetes, was listed on the Nasdaq 100 and was rated as one of the Top 10 places in the industry for scientists to work.

Prior to her time at Amylin, Ginger was Group Chairman, Office of the President for Guidant Corporation, a major cardiovascular medical device manufacturer based in Indianapolis, IN.  During Ginger’s tenure at Guidant, the company launched the world’s leading stent platform, was listed in the Fortune 500, was recognized by Fortune Magazine as one of the Best Companies to Work For in America, and was included in Industry Week Magazine’s 100 Best Managed Companies in the World.

Ginger has received numerous awards and honors including being named as the Emerging Company Executive of the Year by the Global Health Council in 2005, a Finalist in Marketwatch’s CEO of the Year in 2006, and named as the American Diabetes Association’s Woman of Valor award in 2006.  She was included in Pharma VOICE’s “100 of the Most Inspiring People” list in 2006 and World Pharmaceuticals magazine named her number 10 on a list of 40 most influential people in the industry in 2007.  Ginger was the first woman CEO named to the PhRMA Board and Executive Committee.

Ms. Graham serves on the Boards of Directors for Walgreen Co., Genomic Health, Inc., Proteus Digital Health Pharmaceutical Division, Surefire Medical, Elcelyx Therapeutics and the Circle of Life Hospice Foundation.  Ms. Graham is a member of the Harvard Business School Health Industry Alumni Advisory Board, The University of Arkansas Chancellor’s Campaign Steering Committee and the Advisory Board for the BioFrontiers Institute at the University of Colorado.  She also serves on the Advisory Board for the Kellogg Center for Executive Women and co-chairs the Scientific Council of the University of Colorado’s Center for Women’s Health Research.  Graham taught entrepreneurship at Harvard Business School and has written for Harvard Business Review.

Ginger received a Bachelor of Science in agricultural economics from the University of Arkansas, and holds an MBA, with distinction, from Harvard University.

 

back to summit Roger Colman Roger Colman VP, Business Development

Roger Colman is Vice President of Corporate Development for Alticor Corporate Enterprises (ACE), a member of the Amway family of companies.  He is responsible for leading acquisitions for the division and providing business partnerships to acquired non-core entities.

ACE is a holding company for Alticor’s non-direct selling companies, and is the division responsible for adding growth opportunities to the corporation through acquisitions.  The division includes: Amway Hotel Corp.; Gurwitch Products, a luxury cosmetics and skin care company; and Metagenics, a leading manufacturer and distributor of nutraceuticals and medical foods to healthcare practitioners.

Colman joined Alticor in 1994 and has held numerous positions, including his most recent role as Vice President of Finance, overseeing corporate acquisitions.  He has traveled to over 30 countries, assisting local operations in roles including business process improvement and strategic planning.  Prior to joining Alticor, Colman was Director of Operations in the Readi-Bake division for Country Home Bakers of Connecticut.

Colman serves on the boards of Gurwitch Products, LLC, headquartered in Houston and Metagenics, headquartered in Aliso Viejo.  He also is a board member of Interleukin Genetics and Kindex as well as a past board member of Junior Achievement of West Michigan the and Southwest YMCA of Grand Rapids.

Colman received a Bachelor of Science degree and a Master’s of Business Administration degree from Grand Valley State University in Allendale, Mich.

back to summit Jody Holtzman Jody Holtzman SVP, Thought Leadership

Jody Holtzman has more than two decades of experience helping companies develop and implement competitive strategies and achieve their strategic market goals.  At AARP, he leads the Thought Leadership group, where his focus is to stimulate innovation in the market that benefits people over 50. This involves areas such as the future of technology and the 50+, technology design for all, and 50+ entrepreneurship. It also involves developing partnerships with non-traditional players for AARP, such as the venture capital community, and the consumer electronics and technology industries. Previously, Jody led AARP’s Research and Strategic Analysis group.

Before joining AARP, Jody was in senior leadership roles in several strategy consulting firms. He was a Director of Global Strategy and Planning, and led the Market Intelligence Network of PricewaterhouseCoopers. Before that, he was Vice President of Consulting for FutureBrand, where he helped clients develop and implement competitive brand strategies.

Jody is a frequent speaker on the opportunities and challenges presented by the demographic wave. He has led numerous workshops on competitive strategy and organizational performance, and his work has been published in the Journal of Business Strategy, Competitive Intelligence Magazine, The Competitive Intelligence Anthology, and Making Cents Out of Knowledge Management. He has a graduate degree in international political economy from the University of Chicago.

back to summit Steve Basta Steve Basta CEO

Steve Basta is the CEO of AlterG, Inc. a privately held rehabilitation company that commercializes the AlterG Anti-Gravity Treadmill.  Steve has led AlterG since October 2011.  From 2002 through 2011 Steve served as CEO of BioForm Medical, Inc. and its successor, Merz Aesthetics, Inc.   Steve led BioForm’s growth from initial product launch to $80 million in annual revenues.  BioForm went public in 2007 and was acquired by Merz Pharmaceuticals for $250 million in 2009.  Under Steve’s leadership, BioForm became the #3 worldwide dermal filler company, and subsequent to the acquisition, Merz Aesthetics developed the #3 worldwide minimally invasive aesthetics business with direct operations in 16 countries.

Prior to Bioform Medical, Steve served as the CEO of Gliatech, Inc; CFO and VP Business Development of Creative BioMolecules Inc.; Executive Director of Product Development for The Immune Response Coporation; and as an investment banking associate with Dillon Read & Co, Inc.  Steve received his Master of Management degree from the Kellogg Graduate School of Business at Northwestern University, and his bachelor’s degree in biomedical engineering from The Johns Hopkins University.

back to summit Shahab Salemy Shahab Salemy Partner

Shahab Salemy is the Market and Business Development Lead within the SB&I Lab at Nike. In this role, he is focused on new business creation including the sourcing, partnering and incubating of future areas for growth within the broader Nike portfolio. Prior to joining Nike, Mr. Salemy was Senior Director of Strategy and Business Development for Medtronic’s CardioVascular business. At Medtronic he drove the overall portfolio strategy and implemented strategies for entry into the peripheral vascular and hypertension markets. Mr. Salemy has also held roles in strategy and finance at McKesson Corporation and J.P Morgan.

Mr. Salemy holds an MBA from The Wharton School and a BA from Columbia University.

back to summit Thomas Prescott Thomas Prescott President & CEO

Mr. Prescott has been President, CEO and Director of Align Technology, Inc. since April 2002. From May 1999 until August 2001 (when Boston Scientific completed its $115 million acquisition), Mr. Prescott was President, CEO and Director of Cardiac Pathways Corporation. From 1996 until 1999, Mr. Prescott served as Vice President and General Manager of a $200 million respiratory business unit of Nellcor Puritan Bennett (departing after Mallinckrodt completed its acquisition of Nellcor Puritan Bennett), and in other senior leadership roles for Nellcor since 1994. Prior to Nellcor, Mr. Prescott served in various roles at GE Medical Systems as well as Siemens. Mr. Prescott holds a Bachelors in Engineering from Arizona State University and a Masters in Management (MM) from Kellogg Graduate School of Management at Northwestern University. Mr. Prescott also serves as a director for National Children’s Oral Health Foundation.

back to summit Scott Whitcup, MD Scott Whitcup, MD Executive Vice President, Head, R&D and Chief Scientific Officer

Dr. Whitcup is the Executive Vice President, R&D and Chief Scientific Officer at Allergan. Previously, Dr. Whitcup was Senior Vice President and Head of the Ophthalmology Therapeutic Area at Allergan. He is on the faculty at the Jules Stein Eye Institute/David Geffen School of Medicine at UCLA and also serves as a Director on the Board of Avanir Pharmaceuticals and as a member of the Biology Chair’s Council at Caltech.

Dr. Whitcup graduated from Cornell University Medical College and completed residency training both in internal medicine at UCLA Medical Center and in ophthalmology at the Massachusetts Eye and Ear Infirmary-Harvard Medical School. He then received fellowship training in uveitis and ocular immunology at the National Eye Institute at the National Institutes of Health. Prior to coming to Allergan, Dr. Whitcup was Clinical Director of the National Eye Institute, and also served as head of the Clinical Branch and Director of the uveitis and ocular immunology fellowship program. Dr. Whitcup also served as Chair of the NIH Medical Executive Committee.

Dr. Whitcup currently directs Allergan’s discovery efforts and the worldwide clinical development programs that include ophthalmology, neurosciences, dermatology, plastic surgery, obesity, and urology. Dr. Whitcup’s laboratory work has focused on inflammatory disease and the role of cell adhesion molecules in the pathogenesis of autoimmune disease. Dr. Whitcup is an author on over 150 scientific articles, book chapters, and a textbook on ocular inflammatory disease. Dr. Whitcup has been the recipient of numerous awards including the Cogan Award from the Association for Research in Vision and Ophthalmology (ARVO).

back to summit Michael Valentino Michael Valentino Chairman of the Board, Plx Pharma

Michael J. Valentino successfully built start-up Adams Respiratory Therapeutics to nearly $500 million in annual revenue with leading OTC brands such as Mucinex® and Delsym®. Under Mike’s leadership, Adams was ranked by The Wall Street Journal as the No. 1 Health Care IPO in 2005. In December 2007, the Company was acquired by Reckitt Benckiser, for approximately $2.3 billion. Previously, Valentino served as EVP Global Head of Consumer Pharmaceuticals for Novartis. Mr. Valentino was also President of Pharmacia & Upjohn’s Consumer Products Division and previously spent 12 years at Warner Lambert in a variety of senior level roles.

Throughout his career, Mr. Valentino has been at the forefront of 7 major Rx to OTC switches including such well known consumer brands as Benadryl, Rogaine Extra Strength, Motrin Jr., Nasalcrom, Lamisil, Voltaren (EU) and Mucinex. Mr. Valentino served as Chairman of the Consumer Healthcare Products Association Board of Directors in 2001 and 2002. He also served as Vice Chairman of the Board of the Healthcare Institute of New Jersey, a trade association of 22 global pharmaceutical and medical technology companies. Valentino is an Ernst & Young Entrepreneur Of The Year® 2006 award winner in New Jersey for his leadership and achievement in the field of Life Sciences. He was also the recipient of D.A.R.E. New Jersey’s 2006 Future of New Jersey Award.

back to summit Mohit Kaushal, MD, MBA Mohit Kaushal, MD, MBA Partner

Mohit Kaushal is the newest member of the Aberdare team, joining as a partner in 2013.

Mohit has had an extensive career within clinical medicine, venture capital and health policy. He was most recently the inaugural Chief Strategy Officer and Executive Vice President of Business Development at West Health a unique set of entities focused on lowering health care costs through medical research, healthcare policy and investment. He developed the West Health Investment Fund strategy, sourced and led investments in Humedica (acquired by Optum Health), Change Healthcare, RxAnte and goBalto.

Previously, Mohit was the Director of Connected Health with the Federal Communications Commission, where he established the agency’s first dedicated health care team. During his time in the Obama administration, he was also a member of the White House Health IT task force, a cross agency team focusing on implementing the technology aspects of Health Reform. Prior to this position, Kaushal was an investment professional at Polaris Venture Partners, and worked for Merrill Lynch’s Health Care Investment Banking Group and the World Health Organization. Kaushal holds an MBA from Stanford and an MD with distinction from Imperial College, London.

In addition to his role at Aberdare Ventures, Mohit is an Adjunct Assistant Professor of Emergency Medicine at George Washington University and serves on the curation team at TEDMED. He has been appointed to the Consumer Technology Workgroup of the Health IT Standards Committee and to the National Committee on Vital and Health Statistics advising HHS on Data Access and Use.

back to summit Mark Murrison Mark Murrison CEO

Mark Murrison is the founder and CEO of ScaleRx, a business advisory and accelerator to assist companies that compete at the convergence of healthcare and consumerism achieve disruptive growth.  Prior to founding ScaleRx, he has been a leading consumer healthcare executive with over 18 years of leadership experience at Procter & Gamble. Most recently, Mark was the President of MDVIP, the largest concierge medicine company in the US. Under his guidance, MDVIP transformed from a small physician network into a leading consumer healthcare services brand achieving 700% growth. Mark’s experience spans small and large companies as well as mature businesses and start-ups. He led P&G into new categories including consumer medical devices, at home diagnostics, and health services. His success is attributed to a unique ability to see and interpret emerging trends, envision disruptive opportunities to transform a category, and then develop and execute business plans to drive strong growth. He holds an MBA from The University of Texas at Austin and a BS in Business from Kansas State University.